Effective October 1, 2016, the Evonik segment Performance Materials will increase globally the prices for its PMMA molding compounds, which are marketed under the PLEXIGLAS® trademark (in the Americas ACRYLITE®) and also its modified acrylic-based compounds marketed under the trademarks PLEXIMID® (ACRYMID® in the Americas) and XT® Polymer. As far as permissible under existing agreements and according to the product type, the increase will be five percent.
Evonik is committed to supply the highest quality products and services in the industry for acrylics.
Evonik is a worldwide manufacturer of PMMA products sold under the PLEXIGLAS® and PLEXIMID® trademarks on the European, Asian, African and Australian continents and under the ACRYLITE® and ACRYMID® trademarks in the Americas.
Evonik, the creative industrial group from Germany, is one of the world leaders
in specialty chemicals. Profitable growth and a sustained increase in the value of the company form the heart of Evonik’s corporate strategy. Its activities focus on the key megatrends health, nutrition, resource efficiency and globalization. Evonik benefits specifically from its innovative prowess and integrated technology platforms. Evonik is active in over 100 countries around the world. In fiscal 2015 more than 33,500 employees generated sales of around €13.5 billion and an operating profit (adjusted EBITDA) of about €2.47 billion.
Evonik Industries has been producing specialty chemical products in the Greater China region (Mainland China, Hong Kong and Taiwan) since the late 1970’s; with wide-ranging trading relations already in place prior to this in the region. Evonik regards Greater China as one of the driving forces of the global economy and we consequently endeavor to grow our business in the region. The company now has around 3,000 employees in the Greater China region, the regional sales reached over €1.3 billion in 2015.
In so far as forecasts or expectations are expressed in this press release or where our statements concern the future, these forecasts, expectations or statements may involve known or unknown risks and uncertainties. Actual results or developments may vary, depending on changes in the operating environment. Neither Evonik Industries AG nor its group companies assume an obligation to update the forecasts, expectations or statements contained in this release.